The fair value price target for GeneDx Holdings sits at US$170.0, with the latest update keeping this headline target unchanged. Bullish analysts link this steady target to the Wells Fargo upgrade and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results